MetaCap

Health In Tech Inc. Class A (HIT)

NASDAQ: HITFinanceSpecialty InsurersUSD

0.3827+0.0421 (+12.36%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

HIT stock chart

Technical analysis

Key statistics

All statistics
Market cap
$30.50M
EPS (TTM)
-$0.19
52-week range
0.30 – 2.10
Day range
0.3389 – 0.3957
Volume / Avg
182.33K / 177.83K
Beta
—

52-week range

$0.30$2.10

HIT stock today

Shares of Health In Tech (HIT) finished higher on Nov 20 at $0.3827, a gain of 12.36% or $0.0421 per share, versus the S&P 500's 3.70% decline. Shares are 81.8% below their 52-week high of $2.10, set on Mar 10, 2026 and 27.6% above the 52-week low of $0.30, near the bottom of the past year's range. HIT is down 75.9% year to date, underperforming the S&P 500 (+1.2%). Over the past 12 months, the stock has lost 72.5%.

Health In Tech has posted a net loss over the last twelve months (EPS of -$0.19), so its P/E ratio is not meaningful.

Summary generated from market data by MetaCap's automated system. Methodology

About Health In Tech

Company profile

Health In Tech, Inc. operates as an insurance technology platform company in the United States. The company offers reference-based pricing, group insurance captives, community health plans, and association health programs for small businesses; SMR, a program manager specializing in customized self-funded benefits plans for businesses; ICE is, an MGU, which specializes in underwriting and providing administrative functions on behalf of stop loss carriers; and enhance do it yourself benefit system (eDIYBS), a web-based SaaS quoting platform to quote health insurance for small and medium sized employers.

Sector
Finance
Industry
Specialty Insurers
CEO
Mr. Tim Johnson
Headquarters
Stuart, FL
Employees
87
IPO year
2024

Financial highlights

Full financials

In fiscal 2025, Health In Tech generated $33.3 million in revenue, up 71.0% from fiscal 2024, its 2nd consecutive year of revenue growth. Net income was $1.3 million (+90.7% year over year), for a net margin of 3.8% versus a median of 12.1% in the prior 2 years. Gross margin was 62.8% (down from 79.2%).

Health In Tech annual revenue, net income and EPS
Fiscal yearFY 2025FY 2024FY 2023
Revenue$33.33M$19.49M$19.15M
Growth+70.99%+1.77%—
Net income$1.28M$670.48K$3.96M
EPS (diluted)$0.02$0.01—

Analyst forecast

Forecast

Consensus (2 analysts)

strong_buy

Avg. price target

$3.12+715.26%

  • Strong buy 1
  • Buy 1
  • Hold 0
  • Sell 0
  • Strong sell 0

Target range

Low $1.25High $4.10

Ratings and targets reflect third-party analyst opinions, not MetaCap recommendations.

Earnings

Earnings history
Last reported (Sep/2026)
Nov 12, 2026
EPS actual vs est.
$0.01 vs $-0.07
Surprise
+114.29%

HIT news

All HIT news

Health In Tech peers

Finance sector
HIT peer companies
CompanyPrice% ChgMarket capCompare
CCGCheche Group Inc. Class A8.91-1.76%$22.32Mvs HIT
HUIZHuize Holding Limited ADR2.13-9.19%$21.48Mvs HIT
SLQTSelectQuote Inc.5.01-6.36%$45.14Mvs HIT
EHTHeHealth Inc.0.3477+0.93%$11.25Mvs HIT
ZBAOZhibao Technology Inc. Class A0.0938-23.24%$930.60Kvs HIT
RDZNRoadzen Inc.0.9401-1.74%$80.96Mvs HIT
XHGXChange TEC.INC ADR3.33-1.19%$171.65Mvs HIT
TWFGTWFG Inc. Class A25.66+0.86%$331.21Mvs HIT

Indexes, lists and sector

Health In Tech stock FAQ

What is Health In Tech's stock price today?

HIT last traded at $0.3827 as of Nov 20, 4:00 PM EST, up 12.36% on the day. Prices are delayed at least 15 minutes.

Who is Health In Tech's CEO?

Mr. Tim Johnson is the chief executive officer of Health In Tech Inc. Class A, which has about 87 employees.

What is the HIT 52-week high?

The 52-week high for HIT is $2.10 and the 52-week low is $0.30. The stock is currently 81.8% below its high.

Compare HIT